Accel Research Sites - NeuroStudies Clinical Research Unit

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• Alzheimer disease3 trials
• Obesity3 trials
• Type 2 diabetes3 trials
• Type 1 diabetes1 trial

Phase

• Phase 13 trials
• Phase 33 trials

Status

• Active, not recruiting3 trials
• Not yet recruiting3 trials

Lead sponsor

• Eli Lilly and Company6 trials

Running trials

• Not yet recruiting

  A Study of LY4560736 in Healthy Participants and Participants With Alzheimer's Disease (AD)

  NCT07843459· Phase 1· Eli Lilly and Company· Source

  Contact: Marshall Nash (principal investigator)

• Recruiting

  A Master Protocol Studying Multiple Amyloid-Targeting Therapies in Healthy Participants and Participants With Alzheimer's Disease

  NCT07787169· Phase 1· Eli Lilly and Company· Source

  Contact: Marshall Nash (principal investigator)

• Recruiting

  A Study of LY4405094 in Healthy Participants and Participants With Alzheimer's Disease

  NCT07787182· Phase 1· Eli Lilly and Company· Source

  Contact: Marshall Nash (principal investigator)

• Active, not recruiting

  A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Type 2 Diabetes

  NCT06972472· Phase 3· Eli Lilly and Company· Source

• Active, not recruiting

  A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and at Least One Weight-Related Comorbidity

  NCT06972459· Phase 3· Eli Lilly and Company· Source

• Active, not recruiting

  A Master Protocol for Orforglipron (LY3502970) in Participants With Obesity or Overweight With and Without Type 2 Diabetes

  NCT06993792· Phase 3· Eli Lilly and Company· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Alzheimer disease3 recruiting